Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples